NTRK1 and cancer: Cancer cells can therefore master their own destiny, becoming self-sufficient with respect to growth signaling.37,55 Based on an understanding of the underlying cancer biology, various molecular targeting agents, like receptor tyrosine kinase inhibitors, have been developed with excellent success as cancer therapeutics.